A

ApoGlyx

4 employees

Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.

Basic info

biotechnology research

Biotechnology

Aquaporin

Drug Discovery

Sepsis

Type 2 diabetes

2015

$696K

from 1 investors over 1 rounds

A

ApoGlyx raised $696K on October 25, 2021

Investors: Almi Invest